Improving etoposide treatment of Ewing’s sarcoma

Funding Agency: NIH NCI

Title: Improving etoposide treatment of Ewing’s sarcoma

Status: Active

Period: 9/2011-7/2016

Role: Principal Investigator

Grant Detail: To identify genes involved in surviving etoposide exposure and to determine the utility of targeting these genes to improve etoposide treatment of Ewings sarcoma.

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (Greehey CCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to understanding its causes, and accelerate the translation of knowledge into novel therapies. Greehey CCRI strives to have a national and global impact on childhood cancer by discovering, developing, and disseminating new scientific knowledge. Our mission consists of three key areas — research, clinical, and education.

Stay connected with the Greehey CCRI on Facebook, Twitter, LinkedIn, and Instagram.